Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral

September 24, 2012 9:43 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $93.60 --0%

Rating Summary:
    7 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 18 | New: 11
Trade QCOR Now!
Join SI Premium – FREE
Piper Jaffray downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Overweight to Neutral following a U.S. probe into marketing practices. The firm's price target was cut from $67 to $43.

For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.

Shares of Questcor Pharmaceuticals are down 31.6 percent to $20.60.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Piper Jaffray

Add Your Comment